Clin2
NCT04170426Possibly a fitNot yet recruiting

Autologous fat-stem cell treatment for rheumatoid arthritis

Rheumatoid Arthritis

Part of Bones, joints & muscles, Immune system & allergy, Skin clinical trials.

This trial studies whether stem cells made from your own body fat can reduce symptoms of rheumatoid arthritis. Because it uses your own cells, the goal is to see if the treatment is safe and can help with active, hard-to-control disease.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1/Phase 2
Enrollment
54 people
Ages
18 years to 75 years
Study type
Interventional

Who can take part

  • You must have active rheumatoid arthritis that meets accepted classification rules for RA
  • Your RA must be currently active with a certain level of joint swelling/tenderness and long morning stiffness
  • Your blood tests must show RA inflammation or RA-related antibodies (like RF or Anti-CCP) OR high inflammation markers
  • You must have tried at least one anti-rheumatoid medicine and it stopped working or caused side effects, and you must also be on a stable RA regimen for several weeks
  • You must pass infection screening, including tests for HIV, hepatitis B, hepatitis C, and syphilis
  • You must be medically stable with no major health changes for at least 4 weeks before starting

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07639177Not yet recruiting· Phase 2
Fecal Microbiota Transplant for Hard-to-Treat Rheumatoid Arthritis

This trial tests whether transferring healthy gut bacteria from a donor to patients with rheumatoid arthritis that hasn't improved on standard medications can reduce joint pain and swelling. The goal is to see if rebalancing the gut microbiome (the community of bacteria in your intestines) helps control inflammation.

Beijing, Beijing Municipality
NCT05003934Recruiting· Phase 1
IV stem cell treatment safety study for rheumatoid arthritis

This Phase 1 trial tests how safe an intravenous (through a vein) stem cell product is for people with rheumatoid arthritis. It is mainly looking for side effects and safety rather than proving it works yet.

St John's
NCT06888973Enrolling by invitation· Phase 1/Phase 2
Stem cell infusion for autoimmune diseases

This clinical trial is testing if infusions of special stem cells (called mesenchymal stem cells) can help people with certain autoimmune diseases where standard treatments have not worked well enough. It is an early-phase study in Pakistan for adults (and some children for one condition) with rheumatoid arthritis, lupus, systemic sclerosis, ankylosing spondylitis, or dermatomyositis/polymyositis.

Rawalpindi
NCT06947746Recruiting
Studying stem cells for rheumatoid arthritis knee pain

This trial tests if stem cells can improve pain and swelling in the knee for people with rheumatoid arthritis that hasn't responded well to standard treatments. It's for those who still have significant knee symptoms despite taking medications.

Shanghai
NCT04448106Not yet recruiting· Phase 2
Stem cell shot from your own fat for osteoarthritis pain

This Phase 2 study tests whether cells made from your own stored fat can improve osteoarthritis in your knee, hip, or shoulder. It’s for people who already have those fat-derived stem cells banked and who can safely follow the study plan.

Houston, Texas
NCT03984461Recruiting· Phase 2
Platelet-rich treatment with joint fluid or bone cells for arthritis

This trial tests a joint treatment made from your own platelets (platelet-rich plasma, or PRP) combined with other biologic material (from fat tissue and/or bone marrow) to help osteoarthritis symptoms. It may be an option if you have early-to-moderate osteoarthritis in a major joint and meet safety requirements.

Kelowna, British Columbia

Hear when a new Rheumatoid arthritis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.